CD Biosynsis offers comprehensive Saccharomyces cerevisiae Genome Editing Services, utilizing a full suite of precision tools to modify this premier eukaryotic chassis for industrial biotechnology. Saccharomyces cerevisiae (baker's yeast) is a cornerstone of synthetic biology, known for its robust growth, complex eukaryotic machinery, and highly efficient Homology-Directed Repair (HDR) pathway. Our services provide access to advanced CRISPR-based technologies, including CRISPR-Cas9 for large-scale integration and deletion, Base Editing for single-nucleotide precision, and CRISPRi for tunable gene repression. We specialize in providing highly efficient, stable, and markerless modifications that accelerate metabolic pathway optimization, host engineering for tolerance, and rapid production of high-value compounds in the Saccharomyces cerevisiae system.
Get a QuoteEffective metabolic engineering in Saccharomyces cerevisiae requires precise control over gene function—from complete elimination to subtle tuning. Our integrated Genome Editing platform provides all necessary tools to achieve these goals: robust gene deletion for eliminating competing pathways, accurate knock-in for pathway installation, and fine-tuning tools for balancing expression. The ability to leverage the host's natural Homology-Directed Repair (HDR) pathway ensures that all modifications are stable, highly precise, and suitable for industrial scale-up.
Standard editing platform utilizing the yeast's high Homology-Directed Repair (HDR) efficiency for targeted DNA double-strand breaks (DSBs), used for large insertions, deletions, and general genome restructuring.
DSB-free system for highly efficient, clean single-nucleotide conversions (C>T or A>G), perfect for promoter/RBS tuning and precise point mutation introduction in Saccharomyces cerevisiae.
Tunable and reversible gene knockdown (repression) for rapidly optimizing the expression balance of essential genes or native competing pathways without permanent edits.
Permanent, markerless deletion of one or multiple genes to eliminate undesirable byproduct formation or remove competing metabolic pathways.
Accurate insertion of large DNA fragments, such as synthetic operons or full biosynthetic pathways, into specified genomic safe harbor loci via HDR.
Promoter and RBS Tuning
Precise engineering of regulatory elements to control the timing and strength of gene expression, crucial for high-flux metabolism in Saccharomyces cerevisiae.
Metabolic Pathway Installation
Integration and optimization of heterologous genes into the genome to enable the production of novel high-value compounds, leveraging yeast's PTM machinery.
Improved Stress Tolerance
Engineering the host to withstand high concentrations of products, solvents, or temperature fluctuations encountered in industrial fermentation.
Feedstock Flexibility
Modification of native genes or insertion of foreign genes to enable efficient utilization of diverse, low-cost carbon sources (e.g., xylose) for sustainability.
A systematic process for rational design, precise editing, and verification.
1. Rational Design & Strategy
2. Tool Construction & Delivery
3. High-Throughput Screening
4. Verification & Stabilization
Identify all necessary genomic modifications (KO, KI, tuning) using metabolic modeling or predictive analysis.
Design appropriate gRNAs, repair templates with homology arms, and regulatory sequences.
Select the most suitable editing tool (Cas9, BE, or CRISPRi) based on the modification type.
Construct the editing tool expression system (NLS-Cas9/BE) and necessary DNA parts.
Introduce the editing components into the Saccharomyces cerevisiae host via optimized transformation (e.g., LiAc/PEG).
Transiently induce the editing machinery to minimize host stress and off-target effects.
Final confirmation of the clean, markerless genomic edit across all target loci.
If necessary, integrate the final pathway into a stable chromosomal site using the yeast's HDR pathway.
Delivery of the verified Saccharomyces cerevisiae strain and comprehensive editing report.
High Efficiency HDR
Leveraging the yeast's intrinsic, robust Homology-Directed Repair (HDR) system ensures accurate knock-in of large pathways and clean gene deletion, minimizing random mutations.
Full Toolset Coverage
We provide all necessary editing modalities (KO, KI, Repression, Base Editing), allowing us to choose the most efficient and precise tool for any genomic target in Saccharomyces cerevisiae.
Eukaryotic Precision
Specialized NLS-Cas9 systems ensure efficient delivery and function within the yeast nucleus, overcoming the compartmentalization barrier inherent in eukaryotic hosts.
Markerless and Stable
All permanent modifications are performed markerlessly and integrated into the chromosome, guaranteeing strain stability and suitability for industrial scale-up without antibiotic pressure.
1. Why is the HDR pathway so important for editing Saccharomyces cerevisiae?
The highly active HDR pathway allows the cell to accurately incorporate large donor DNA fragments (the repair template) at the CRISPR-Cas9 cut site, resulting in very high rates of precise gene insertion (knock-in) and clean deletion.
2. What is the maximum size of DNA you can integrate into the genome?
Utilizing the efficient HDR system, Saccharomyces cerevisiae is capable of integrating very large pathways (e.g., 10-50 kb) in a single step, making it ideal for synthesizing complex molecules requiring many enzymes.
3. Can you perform multiple simultaneous genomic modifications?
Yes. We use multiplexed CRISPR systems to introduce several edits (knockouts or knock-ins) in a single step. The multiplex strategy minimizes the project timeline compared to sequential editing.
4. How is the editing system transported into the yeast nucleus?
The Cas9 and Base Editor enzymes are fused to a Nuclear Localization Signal (NLS), which actively transports the editing machinery from the cytoplasm across the nuclear membrane to access the genomic DNA.
5. What is the benefit of using Base Editing for gene tuning?
Base Editing provides single-base precision to modify regulatory sequences (promoters, RBS) without creating a DNA double-strand break, which is safer and more efficient than standard Cas9 for fine-tuning gene expression.
6. Is the final engineered strain free of foreign DNA (markerless)?
Yes. For all permanent modifications, we employ markerless techniques, often using counter-selection or marker recycling, to ensure the final delivered strain is free of residual antibiotic resistance genes.
7. How is the edited strain verified upon project completion?
We provide full verification via genotype confirmation (junction PCR, Sanger sequencing) and phenotype analysis (measuring growth rate, product titer, or stress tolerance) to ensure the edit is both precise and functional.
8. Can you perform genome editing on industrial polyploid Saccharomyces cerevisiae strains?
Yes. While more complex, our optimized CRISPR protocols are effective in industrial, polyploid strains. We use specific selection and screening strategies to ensure successful editing and verification across all target alleles.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.